Exclusive

Publication

Byline

Location

US Patent Issued to SunRegen Healthcare on April 7 for "Lipids with odd number of carbon atoms and their use as pharmaceutical composition or nutritional supplement" (Chinese, Swiss Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,255, issued on April 7, was assigned to SunRegen Healthcare AG (Reinach, Switzerland). "Lipids with odd number of carbon atoms and their us... Read More


US Patent Issued to ANAVEX LIFE SCIENCES on April 7 for "A19-144, A2-73 and certain anticholinesterase inhibitor compositions and method for anti-seizure therapy" (New Jersey, New York Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,256, issued on April 7, was assigned to ANAVEX LIFE SCIENCES CORP. (New York). "A19-144, A2-73 and certain anticholinesterase inhibitor com... Read More


US Patent Issued to THE REGENTS OF THE UNIVERSITY OF MICHIGAN on April 7 for "Inhibitors of MHC-I Nef downmodulation for treating HIV" (Michigan Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,258, issued on April 7, was assigned to THE REGENTS OF THE UNIVERSITY OF MICHIGAN (Ann Arbor, Mich.). "Inhibitors of MHC-I Nef downmodulati... Read More


US Patent Issued to ACCURE THERAPEUTICS on April 7 for "Treatment regimen for the treatment of neurological diseases or conditions" (California Inventor)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,259, issued on April 7, was assigned to ACCURE THERAPEUTICS S.L. (Barcelona, Spain). "Treatment regimen for the treatment of neurological d... Read More


US Patent Issued to Topical Rx on April 7 for "Topical formulations for infections" (Oklahoma Inventor)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,260, issued on April 7, was assigned to Topical Rx LLC (Tulsa, Okla.). "Topical formulations for infections" was invented by David A. Stoll... Read More


US Patent Issued to SHANGHAI EAST HOSPITAL (EAST HOSPITAL, TONGJI UNIVERSITY SCHOOL OF MEDICINE) on April 7 for "Use of heterocyclic derivatives with cardiomyocyte proliferation activity for treatment of heart diseases" (Chinese Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,261, issued on April 7, was assigned to SHANGHAI EAST HOSPITAL (EAST HOSPITAL, TONGJI UNIVERSITY SCHOOL OF MEDICINE) (Shanghai). "Use of he... Read More


US Patent Issued to ForwardVue Pharma on April 7 for "CAI nanoemulsions" (Alabama Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,262, issued on April 7, was assigned to ForwardVue Pharma Inc. (Mobile, Ala.). "CAI nanoemulsions" was invented by Alan J. Franklin (Mobile... Read More


US Patent Issued to NURIX THERAPEUTICS on April 7 for "CBL inhibitors and compositions for expansion of immune cells" (California Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,263, issued on April 7, was assigned to NURIX THERAPEUTICS INC. (San Francisco). "CBL inhibitors and compositions for expansion of immune c... Read More


US Patent Issued to ARVINAS OPERATIONS on April 7 for "Modulators of alpha-synuclein proteolysis and associated methods of use" (Connecticut, New Jersey Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,264, issued on April 7, was assigned to ARVINAS OPERATIONS INC. (New Haven, Conn.). "Modulators of alpha-synuclein proteolysis and associat... Read More


US Patent Issued to Ohio State Innovation Foundation on April 7 for "Methods and compositions for inhibition of STAT3" (Ohio, Florida Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,265, issued on April 7, was assigned to Ohio State Innovation Foundation (Columbus, Ohio). "Methods and compositions for inhibition of STAT... Read More